Google+ Badge

Monday, June 1, 2015

Health News: 150 people exposed to Lassa Fever ♦ Can chronic wasting disease spread to humans ♦ Psychedelic drugs should be legally reclassified

CDC: 150 people possibly came in contact with man who died of Lassa Fever The Centers for Disease Control and Prevention (CDC) announced May 28 that health officials are monitoring over 150 people who may have come in contact with a New Jersey man who died of Lassa fever in Newark’s University Hospital May 25. At least 6 are reported to have a high risk of exposure, and another 33 are at a low risk
Can chronic wasting disease spread to humans An infectious brain disease that has been killing deer, elk and moose both in the wild and on “captive farms” continues to stalk the land, expanding its domain to 23 states and two Canadian provinces since it was first identified in captive mule deer in a Colorado research facility in 1967. Known as chronic wasting disease,...
Cultural health beliefs and social networks crucial in South Asian people's management of diabetes New findings shed light on the poor outcomes of South Asian people with diabetes in the UK. Analysis of interviews with South Asian people shows that especially among first generation immigrants, fatalistic and treatment beliefs are often a hindrance to managing the condition
Psychedelic drugs should be legally reclassified as they may benefit patients Legal restrictions imposed on medical use of psychedelic drugs, such as LSD and psilocybin (the compound found in 'magic' mushrooms), are making trials almost impossible and authorities should 'downgrade their unnecessarily restrictive class A, schedule 1 classification,' writes a psychiatrist.
Nivolumab treatment in melanoma patients has manageable safety profile The monoclonal antibody nivolumab has shown promise as a therapeutic agent, particularly by improving the survival rates of melanoma patients. Medical researchers have presented data from a retrospective analysis of the safety of nivolumab in 4 ongoing phase I-III studies in melanoma patients

No comments:

Post a Comment